Vanguard Group’s Benitec Biopharma BNTC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
969,166
+642,132
| +196% | +$7.51M | ﹤0.01% | 2834 |
|
|
2025
Q1 | $4.25M | Buy |
327,034
+27,013
| +9% | +$351K | ﹤0.01% | 3236 |
|
|
2024
Q4 | $3.79M | Buy |
300,021
+86,954
| +41% | +$1.1M | ﹤0.01% | 3373 |
|
|
2024
Q3 | $1.96M | Sell |
213,067
-2,003
| -0.9% | -$18.4K | ﹤0.01% | 3564 |
|
|
2024
Q2 | $1.5M | Buy |
215,070
+198,369
| +1,188% | +$1.39M | ﹤0.01% | 3655 |
|
|
2024
Q1 | $87.7K | Hold |
16,701
| – | – | ﹤0.01% | 4255 |
|
|
2023
Q4 | $53.9K | Buy |
+16,701
| New | +$53.9K | ﹤0.01% | 4364 |
|
|
2023
Q3 | – | Sell |
-74,773
| Closed | -$17.8K | – | 4546 |
|
|
2023
Q2 | $17.8K | Hold |
74,773
| – | – | ﹤0.01% | 4523 |
|
|
2023
Q1 | $15.7K | Hold |
74,773
| – | – | ﹤0.01% | 4536 |
|
|
2022
Q4 | $12.7K | Hold |
74,773
| – | – | ﹤0.01% | 4504 |
|
|
2022
Q3 | $28K | Sell |
74,773
-3,598
| -5% | -$1.35K | ﹤0.01% | 4577 |
|
|
2022
Q2 | $91K | Hold |
78,371
| – | – | ﹤0.01% | 4557 |
|
|
2022
Q1 | $183K | Hold |
78,371
| – | – | ﹤0.01% | 4546 |
|
|
2021
Q4 | $205K | Hold |
78,371
| – | – | ﹤0.01% | 4557 |
|
|
2021
Q3 | $280K | Buy |
78,371
+3,598
| +5% | +$12.9K | ﹤0.01% | 4456 |
|
|
2021
Q2 | $318K | Buy |
74,773
+22,579
| +43% | +$96K | ﹤0.01% | 4324 |
|
|
2021
Q1 | $270K | Buy |
+52,194
| New | +$270K | ﹤0.01% | 4226 |
|